Crossmark

Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study

Crossref DOI link: https://doi.org/10.1186/s13613-021-00810-y

Published Online: 2021-02-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan, Cze-Ci

Lee, Kuang-Tso

Ho, Wan-Jing

Chan, Yi-Hsin

Chu, Pao-Hsien http://orcid.org/0000-0003-0361-6348
Funding

Funding for this research was provided by:

Chang Gung Medical Foundation (CMRPG3K0191)
License Information

Text and Data Mining valid from 2021-02-08

Version of Record valid from 2021-02-08
More Information

Article History

Received: 4 August 2020

Accepted: 18 January 2021

First Online: 8 February 2021

Ethics approval and consent to participate

: This study has been approved by the Institutional Review Board of the Chang Gung Medical Foundation, 201901349B0.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below